Brief: Cstone Pharmaceuticals - Frank Ningjun Jiang Decided To Retire As CEO
25/08/2022 12:02
CStone Pharmaceuticals 2616.HK :
* CSTONE PHARMACEUTICALS - FRANK NINGJUN JIANG DECIDED TO
RETIRE
AS CEO
* CSTONE PHARMACEUTICALS - FRANK NINGJUN JIANG DECIDED TO
RETIRE
AS EXECUTIVE DIRECTOR
* CSTONE PHARMACEUTICALS - JIANXIN YANG APPOINTED AS CEO,
EXECUTIVE DIRECTOR
Source text for Eikon: ID:nHKS8cXCxp
Further company coverage: 2616.HK
Recent news on CStone Pharmaceuticals
See all newsBrief: CStone Pharmaceuticals Says CEO Purchases 496,000 Shares For Over HK$2.7 Million From Sept 17-22
Brief: CStone Pharmaceuticals Posts HY Loss Of Rmb252.3 Million
China's CStone Pharmaceuticals H1 revenue soars on drug sales
Brief: Cstone Pharmaceuticals Receives NMPA IND Approval For CS5007 In China
Brief: CStone Pharmaceuticals Says Directors And Senior Management Purchase 2.4 Million Shares In June 2026